US Needs to Increase HIV-1 Subtype Surveillance CDC Daily UpdateImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




US Needs to Increase HIV-1 Subtype Surveillance

Reuters Health Information Services (12/29/97)


Abstract: In the December issue of the Journal of Infectious Diseases, researchers report the first documented case of HIV-1 subtype A infection in a United States-born individual who has not traveled outside of the country. The researchers--led by Dr. Kathleen Irwin of the Centers for Disease Control and Prevention--studied 43 HIV-1-infected patients in New York City and found that most were infected with HIV subtype B, the most common strain in the United States and Western Europe. Of the two patients with HIV-1 subtype A, the team said the infections appear to have been contracted while in the United States, but non-locally acquired infection is also possible for the subject born in Africa. The findings highlight the need for increased HIV-1 subtype surveillance in the United States, the researchers concluded.


971230
AD972375


Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.